Ascend Laboratories, LLC

Ascend Laboratories, LLC: 6 recalls listed since May 2026 across FDA.

By year

20266

By agency

FDA6

By category

Drug6

All recalls (6)

FDA•Jul 24, 2026LOW
Ascend Laboratories: Multiple Dabigatran Etexilate Capsules
Ascend recalls Dabigatran Etexilate 75mg/150mg capsules over impurity spec failures.
6 products
FDA•Jul 17, 2026LOW
Ascend Laboratories: Multiple Dabigatran Etexilate Capsules
Ascend recalls Dabigatran etexilate capsules (110 mg, 150 mg) over impurity test failures.
2 products
FDA•Jul 17, 2026MODERATE
Amlodipine and Olmesartan Medoxomil Tablets
Ascend Laboratories is recalling Amlodipine and Olmesartan Medoxomil Tablets (10 mg/20 mg) due to failed dissolution specifications.
FDA•Jun 10, 2026MODERATE
Minocycline Hydrochloride 115 mg Tablets
Ascend Laboratories is recalling Minocycline Hydrochloride 115 mg tablets due to failed dissolution specifications.
FDA•Jun 2, 2026MODERATE
Amlodipine and Olmesartan Medoxomil Tablets
Ascend Laboratories is recalling Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg, due to failed dissolution specifications.
FDA•May 11, 2026MODERATE
Metoprolol Succinate Extended-Release Tablets 25 mg
Ascend Laboratories is recalling 25 mg Metoprolol Succinate Extended-Release Tablets due to failed dissolution testing.